Literature DB >> 18954785

Optimal surgical performance attenuates physiologic risk in high-acuity operations.

Wande Pratt1, Mark P Callery, Charles M Vollmer.   

Abstract

BACKGROUND: The interplay between baseline physiology, operative performance, and postoperative recovery is poorly defined. We describe the beneficial effect of a successful operation on outcomes across the full spectrum of physiologic risk for an elective high-acuity procedure. STUDY
DESIGN: Four hundred twelve consecutive pancreatic resections, performed between 2001 and 2008, were analyzed according to the Physiologic and Operative Severity Score for the Enumeration of Mortality and Morbidity. Baseline physiology was classified according to the Physiologic Severity Score: minor (< or = 16); intermediate (17 to 23); vulnerable (> or = 24). Surgical performance was assigned by the Operative Severity Score: class I (< or = 14); class II (15 to 17); class III (> or = 18). Physiologic and operative predictions were independently correlated with actual clinical and economic outcomes and then merged to measure the influence of surgical performance beyond baseline physiology.
RESULTS: As baseline physiology declines, patients suffer more complications and require more therapeutic and invasive interventions. Within each physiologic risk grade, class I operations (optimal surgical performances) were associated with lower rates of morbidity, shorter hospital stays, and improved cost efficiency. Deeper analysis reveals that intraoperative blood loss is the most variable and influential factor affecting physiologic risk. Each additional unit (375 mL) of blood loss increases the odds of morbidity by 45%, prolongs hospital stay by 1 day, and costs an additional $4,000 per patient.
CONCLUSIONS: Predictive risk assessment accurately demonstrates that escalating physiologic risk worsens postoperative morbidity, prolongs hospital duration, and increases costs after such high-acuity operations. These effects are attenuated by improved operative performance.

Entities:  

Mesh:

Year:  2008        PMID: 18954785     DOI: 10.1016/j.jamcollsurg.2008.06.319

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

1.  A root-cause analysis of mortality following major pancreatectomy.

Authors:  Charles Mahlon Vollmer; Norberto Sanchez; Stephen Gondek; John McAuliffe; Tara S Kent; John D Christein; Mark P Callery
Journal:  J Gastrointest Surg       Date:  2011-11-08       Impact factor: 3.452

2.  Assessment of health care cost for complex surgical patients: review of cost, re-imbursement and revenue involved in pancreatic surgery at a high-volume academic medical centre.

Authors:  Swapnil D Kachare; Kendall R Liner; Nasreen A Vohra; Emmanuel E Zervos; Todd Hickey; Timothy L Fitzgerald
Journal:  HPB (Oxford)       Date:  2014-10-09       Impact factor: 3.647

3.  The obstructed pancreatico-biliary drainage limb: presentation, management, and outcomes.

Authors:  David D Odell; Wande B Pratt; Mark P Callery; Charles M Vollmer
Journal:  J Gastrointest Surg       Date:  2010-06-22       Impact factor: 3.452

4.  A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.

Authors:  Russell Lewis; Jeffrey A Drebin; Mark P Callery; Douglas Fraker; Tara S Kent; Jenna Gates; Charles M Vollmer
Journal:  HPB (Oxford)       Date:  2012-09-24       Impact factor: 3.647

5.  How to improve the performance of intraoperative risk models: an example with vital signs using the surgical apgar score.

Authors:  Joseph A Hyder; Daryl J Kor; Robert R Cima; Arun Subramanian
Journal:  Anesth Analg       Date:  2013-12       Impact factor: 5.108

6.  Risk Factors and a New Prediction Model for Pancreatic Fistula After Pancreaticoduodenectomy.

Authors:  Jia-Yu Zhang; Jia Huang; Su-Ya Zhao; Xin Liu; Zhen-Cheng Xiong; Zhi-Ying Yang
Journal:  Risk Manag Healthc Policy       Date:  2021-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.